Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Angel Artal

Head of Section

Mie University Hospital

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Imaging Medical Imaging professors in Spain

About

Angel Artal is the Head of Section at Hospital Universitario Miguel Servet in Spain. His research areas include lung cancer, specifically focusing on immunotherapy, angiogenic biomarkers, and the psychosocial impacts of the disease. He has contributed to significant studies on immunotherapy outcomes, symptom palliation in bone metastases, and the role of lung microbiota in cancer development and treatment. His recent publications reflect a commitment to advancing understanding and care for patients with non-small cell lung cancer.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Oscar Juan-Vidal

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Angel Artal

Research Interests

Explore related searches

About

Articles (10)

Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy

External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline.

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.

Opening Windows for Thymic Tumors

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program.

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.

Assessment of the psychosocial and economic impact according to sex in non-small cell lung cancer patients: an exploratory longitudinal study.

The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy.

ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort.

Collaborators (1)

Oscar Juan-Vidal

Make your next move.